Patent details

EP2877164 Title: AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS

Basic Information

Publication number:
EP2877164
PCT Application Number:
US2013051880
Type:
European Patent Granted for LU
Legal Status:
Unitary Effect Registered
Application number:
EP138221668
PCT Publication Number:
WO2014018668
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
AEROSOL PIRFENIDONE AND PYRIDONE ANALOG COMPOUNDS
French Title of Invention:
COMPOSÉS ANALOGUES DE PIRFÉNIDONE ET DE PYRIDONE POUR AÉROSOL ET LEURS UTILISATIONS
German Title of Invention:
AEROSOLPIRFENIDON UND PYRIDONANALOGVERBINDUNGEN
SPC Number:

Unitary Effect

Unitary Effect Requested:
Yes
Unitary Effect Request Filing Date:
12/07/2023
Link to UPP Register:
European Patent Register
Unitary Effect Request Withdrawal Date:
Unitary Effect Status:
Unitary Effect Registered
Unitary Effect Acceptance Decision Date:
21/07/2023
Unitary Effect Rejection Decision Date:
Unitary Effect Date:
05/07/2023
Unitary Effect Registration Date:
21/07/2023
Unitary Effect Re-establishment of rights Filing Date:
Unitary Effect Re-establishment of rights EPO Decision :
Unitary Effect Re-establishment of rights EPO Decision Date:
Explanatory Text UE:
Safety Net Request Date:
Safety Net Decision Date:
Safety Net Decision Outcome:
SPC Number:

Dates

Filing date:
24/07/2013
Grant date:
05/07/2023
EP Publication Date:
03/06/2015
PCT Publication Date:
30/01/2014
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
05/07/2023
EP B1 Publication Date:
05/07/2023
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
Expiration date:
24/07/2033
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
06/10/2023
 
 

Name:
Avalyn Pharma Inc.
Address:
701 Pike Street, Suite 1500, Seattle, WA 98101, United States (US)

History of Owners

From:
28/06/2023
To:
06/10/2023

Name:
Avalyn Pharma Inc.
Address:
12636 High Bluff Drive, Suite 400, San Diego, CA 92130, United States (US)

Inventor

Name:
SURBER, Mark, William
Address:
United States (US)

Priority

1

Priority Number:
201261675286 P
Priority Date:
24/07/2012
Priority Country:
United States (US)

2

Priority Number:
201361756983 P
Priority Date:
25/01/2013
Priority Country:
United States (US)

3

Priority Number:
201361824818 P
Priority Date:
17/05/2013
Priority Country:
United States (US)

Classification

IPC classification:
A61K 9/00; A61K 31/4412; A61K 31/4418; A61P 11/00; A61P 35/00;

Publication

European Patent Bulletin

1

Issue number:
202327
Publication date:
05/07/2023
Description:
Grant (B1)

2

Issue number:
202333
Publication date:
16/08/2023
Description:
Unitary Effect Request Receipt

3

Issue number:
202334
Publication date:
23/08/2023
Description:
Unitary Effect Request Acceptance

4

Issue number:
202345
Publication date:
08/11/2023
Description:
Change of owner's name or address

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages